The gastrin-releasing peptide receptor (GRPR), also known as bombesin receptor subtype 2 (BB2), is expressed in various tumors, including prostate, breast, lung, colorectal, cervical cancers, and cutaneous melanoma. Here, GRPR is linked to cervical carcinoma.